skip to content

School of the Biological Sciences

 

Group Leader, Milner Therapeutics Institute 

Konstantinos Tzelepis's group is uncovering epigenetic and epitranscriptomic mechanisms that are implicated in cancer initiation and maintenance. Learn more

 

Research Areas


Cancer epigenetics
Acute myeloid leukaemia
Technology development
Novel therapeutics

Techniques


CRISPR
Genetic Screening
 
 

 

Research Theme